Shanghai laboratory
A Shanghai-based biotechnology team supporting analytical questions across biologics research and development.
Biopharma Analytical Services
Analytical clarity for complex biologics
APDK supports antibody, ADC, recombinant and fusion protein, and peptide programs with integrated characterization across identity, variants, aggregation, binding, potency, and impurity questions.
At a Glance
A Shanghai-based analytical partner for biologics programs.
Three product lines
Antibodies and ADCs, recombinant and fusion proteins, and peptides.
Verified credentials
CNAS Accreditation No. L18600 and ISO 9001 Certificate J25Q2SH8026349R1S.
Accreditation applies only to activities within the current formal CNAS scope. Method-specific applicability is confirmed during project scoping.
Review quality and credentialsServices
Start with the product and the development question.
Choose the product context closest to your program. We will shape the analytical scope around the decision your data needs to support.
01
Antibody & ADC Analytics
Connect molecular format, conjugation strategy, product variants, function, and impurity questions to the next development decision.
Explore service 02Recombinant & Fusion Protein Analytics
Address construct identity, heterogeneity, aggregation, stability, function, and process-related questions in product context.
Explore service 03Peptide Analytics
Frame identity, modification, purity-related, impurity, and stability questions around sequence and sample history.
Explore serviceAnalytical Coverage
Connect concrete methods to the attribute and decision in scope.
A project may combine the methods below into one core package and selected modules. Feasibility, method suitability, sample needs, and final deliverables are confirmed before project start.
Identity & primary structure
Intact or subunit mass, peptide mapping, sequence, termini, disulfide, and free-thiol questions as applicable.
Purity, size & aggregation
SEC and CE-SDS, with SEC-MALS/AUC, DLS, or MFI selected where the product question requires them.
Charge, glycans & PTMs
iCIEF or IEX, glycan analysis, and agreed heterogeneity or post-translational-modification questions.
Binding & potency
SPR/BLI, ELISA, or cell-based assays selected around intended function and the decision to be supported.
ADC conjugation questions
Conjugation-site mapping and agreed ADC structural questions, linked to the molecular format and program context.
Process-related impurities
Agreed residual targets and reporting boundaries defined from the process context before work begins.
Project Package
What you send. What we agree. What you receive.
Feasibility, method suitability, and final deliverables are confirmed before project start.
You send
- Sequence or construct
- Sample form and amount
- Program stage and decision
We agree
- Core package and options
- Sample plan and controls
- Reporting format
You receive
- Scoped project plan
- Traceable figures and tables
- Integrated result summary
How We Work
A direct path from project context to reviewed delivery.
- 01
Scope
Align on the product, development stage, and decision to be supported.
- 02
Sample & Method Review
Review sample constraints, references, comparisons, and analytical fit.
- 03
Analysis
Execute the agreed work with traceable sample and data handling.
- 04
Scientific Review
Interpret findings against the agreed question and evidence boundaries.
- 05
Delivery
Provide a clear report and a technical discussion of the results.
Why APDK
Built for biologics teams that need connected analytical reasoning.
Cross-method evidence
Bring complementary observations together around one product question instead of treating each result in isolation.
Development-stage focus
Keep the scope and interpretation tied to the decision required at the current stage.
Direct technical collaboration
Work directly with the technical team shaping the scope and reviewing the findings.
Quality & Credentials
Verified credentials with a clear scope boundary.
APDK publishes approved certificate fields while keeping method-specific accreditation and project suitability subject to confirmation.
CNAS
Accreditation No. L18600 · ISO/IEC 17025:2017 and CNAS-CL01 · Valid 05 Jul 2023–04 Jul 2029
ISO 9001
Certificate J25Q2SH8026349R1S · ISO 9001:2015 / GB/T 19001-2016 · Valid through 06 Nov 2028
- Project scope and method suitability confirmed before start
- Traceable sample, data, method, and review handoffs
- Technical review and report approval before delivery
Accreditation applies only to activities within APDK’s current formal CNAS scope. Whether a specific method or project activity is within scope must be confirmed during project scoping.
See our quality approachStart a Conversation
Tell us what decision your data needs to support.
Share your product type, development stage, current analytical question, and practical sample context. A concise, non-confidential summary is enough to begin.
bd@aipudikang.com